Pulmonary Function Testing Sandra B. Weibel MD Thomas Jefferson University.

80
Pulmonary Function Testing Sandra B. Weibel MD Thomas Jefferson University

Transcript of Pulmonary Function Testing Sandra B. Weibel MD Thomas Jefferson University.

Pulmonary Function Testing

Sandra B. Weibel MD

Thomas Jefferson University

Indications

• Differential diagnosis of dyspnea

• Provides objective assessment of symptoms versus severity

• Determine fitness for surgery

• To guide therapy

• To follow the course of a disease

Physiologic classification of disease

• Obstructive Impairment- Airway limitation due to the resistive properties of the respiratory system

• Restrictive Impairment- Loss of volume capacity of the lung due to loss of air space units or inability to expand the respiratory system

Obstructive Processes

• L ocal obstruction

• A sthma

• C hronic bronchitis (COPD)

• E mphysema

Restrictive Processes

• P leural disease

• A lveolar filling processes

• I nterstial lung disease

• N euromuscular diseases

• T horacic cage abnormailites

Spirometry

• Most widely performed study and is important in initial screening of patients

• Easily and quickly performed in many settings

Types of spirometers

• Types include flow (pneumotach) or volume (water seal, rolling and diaphragm)

• Water seal device previoisly most commonly used in pulmonary function labs of the volume– Collect exhaled gas and act as a reservoir for

inhaled gas– Composed of a mouthpiece, bell system and a

pen on a rotating drum

Volume Displacement Spirometer

Flow Spirometry

Calibration of spirometer

• Warmed up and temperature controlled Barometric pressure and temperature recorded

• Volume calibration with 3L syringe (within 3%)

• Flow spirometer tested at 3 flow rates between 2 and 12L

Quality Control

Prior to testing

Performing the maneuver

• It is a forced expiratory maneuver and the patient must be sitting upright in a chair with lips around a mouthpiece

• After a maximal inspiration, a forced and rapid expiration is made

• Quality of the maneuver needs to be assessed noting that the patient started at zero, had a maximal initial efffort and lasted 6 seconds.

Measurements

• FVC

• FEV1

• FEV1/FVC

• Also FEF25-75 and TET

FVC Measurement

FEV1 Measurement

Flow volume

Interpretation

• First need to assess the quality of the maneuvers

• Choice of reference values

• Use of LLN

• Compare to previous tests

• Race adjustments

Interpretation

• Restrictive Lung– FVC AND FEV1

decreased

– FEV1/FVC normal

– FEV1 main distinguishing feature

• Obstruction– FEV1 decreased

– FVC Normal

– FEV1/FVC are low

Pitfalls in Interpretation

• Predicted need to fit your population

• Non Caucasians have lower lung volumes and this may need to be addressed

• Prior to interpretation the test needs to be assessed to see if it meets standards

• Machines need to be calibrated daily to ensure accuracy

Effort

Poor effort

Interpretation

• The patient’s data is compared to predicted

• Predicted values are obtained after studying populations of normal nonsmokers and then regression equations developed

• Regressions are based on sex, height, and age.

Predicted Values

Decline in PFTS

References

• Many different ones used in past Knudson Crapo etc

• Current recommendation is NHANES III

• This studied over 7000 individuals

• Included Caucasians, blacks and Mexican Americans

Interpretaion

• Normal is > 80% of predicted– Mild impairment 65-79%– Moderate 50 -64%– Severe < 50%

Interpretations

Flow Volume Loops

• Inspiratory loops can also be obtained to evaluate for the presence of large airway obstruction

• Theory changes in pressure outside and inside the thoracic cage will cause changes in airway diameter

• These airway changes can cause a limitation to airflow if large enough

Extrathoracic Obstruction

Intrathoracic Obstruction

Fixed Obstruction

Large Airway Obstruction

Bronchodilator Response

Bronchodilator testing

• No short acting agents for 4 hrs

• No long acting beta agonists for 12 hrs

• No theo for 12 hrs

• No smoking for 1 hr

• Beta agonist given recommended 4 puffs and wait 10-15 minutes later

Performance of the Maneuver

Peak Flow Measurements

• Convenient portable device for measuring peak expiratory flow in l/min

• May be less reliable than spirometry but easy to use and inexpensive

• Useful to follow the course of asthma and to possibly look and work exposure

• Technique

Lung Volumes

• May be measured by multiple methods

• Is important to understand what volumes the lung is composed of

• The total volume of the lung is TLC

• The subdivisions include ERV, IRV, TV,and RV

• Capacities are composed of 2 or more volumes.

Helium Dilution Technique

• Uses an inert gas, helium and by a closed circuit technique, allow it to come to equilibrium and FRC is measured

• May underestimate lung volumes in bullous lung disease

Nitrogen Washout

• Determine FRC by multiple breath open circuit nitrogen washout

• Involves having nitrogen in patients lung being washed out by inhaling 100% O2 for several minutes.

• Widely used, easy to perform but may underestimate bullous lung disease

Nitrogen Washout

• Performed by having the patient breath comfortably for several minutes and then turn in to 100% O2 at FRC.

• Monitor N2 concentrations and test ends when falls below 1%

• Easy to see leaks

Nitrogen Washout

• Concept is C1V1= C2V2– C1 = Nitrogen concentration at the start of the

test– V1 = FRC volume– C2 =N2 concentration in exhaled volume– V2 = Total exhaled volume during O2

breathing period– Nitrogen is measured by photoelectric principle

Body Plethsymography

• Is a sealed box with a fixed volume

• Uses Boyle’s Law that changes in pressure are brought about by changes in volume for the person seated in the box

• P1V1= P2V2

Body Plethysmograph

Lung volume measurements

• FRC is directly measured as well as SVC

• Other volumes and capacities can be calculated

• Lung volume measurements are important to confirm RLD

• TLC and RV the usual volumes assessed

Interpretation

• RLD– TLC is reduced in all

– Predicted values and interpret same as FVC and FEV1

• OLD– TLC can be increased

and is then called hyperinflation (120%)

– RV can be increased in asthma and COPD indicating air trapping

Diffusing Capacity

• Provides information about the transfer of gas between the alveoli and the pulmonary capillary bed

• It is the only noninvasive test of gas exchange

• Performed by a single breath technique and uses CO as the inert gas

Diffusing Capacity

• Diffusion of a gas is dependent of the area, the concentrations, the thickness of the membrane and the diffusing properties of the gas

• Diffusion is the rate at which a gas is transferred across the alveolar capillary membrane, the plasma, the RBC and ultimately combined with Hgb

Diffusing Capacity

• CO is typically used because it is freely diffusable

• It usually is not present in significant amounts in the blood except in some heavy smokers

• Helium or methane is also used to measure volume

• A single maximal inspiration is taken and held for 10 sec

Diffusing Capacity

• Normal result is >80%

• Can be reduced in interstitial diseases such as sarcoid or asbestosis

• Can be reduced also in emphysema or pulmonary vascular diseases

• False low measurements in anemia or lung resection and elevated in alveolar hemm

Summary

• Spirometry- Most commonly performed and useful screening test.

• Lung volumes- Can be measured several different ways. Are used to evaluate for restrictive disease and will also show air trapping

• Diffusing Capacity - Transfer of gas across the alveolar membrane

Selecting Tests

• Who should get what test

• Who cannot get certain tests

• Which method of lung volume testing

• Inpatients

Case 1

• A 25 year old female comes to your office complaining of chest tightness and shortness of breath with running.

• Exam is normal

• What tests would you order?

Spirometry

• Pre – FVC 2.64 90%

– FEV1 1.83 79%

– FEV1/FVC 69

– TET 5.0

– FEFmax 4.85 L/S

• Post– 3.12 106%

– 2.21 95% (18%)

– FEV1/FVC 71

– TET 5.5

– FEFmax 5.02 L/S

Case 2

• A 58 year old male presents to office complaining of dyspnea on exertion over the last 6 months. He has a dry cough but no other complaints. He has smoked 1ppd for 35 years and works in construction.

PFTS

• FVC 1.43 48%• FEV1 1.30 57%• FEV1/FVC 91• TLC 3.05 63%• RV1.53 68%

• Dsb 5.78 24%• Dsb(adj) 7.8 33%• VA 2.3 42%• D/VA 2.51 57%• Hsb 11.4